Mathias Goyen, Chief Medical Officer EMEA,
GE HealthCare is putting personalised care at the core of molecular imaging. We have imagined and opened a new era in healthcare with Theranostics, supporting a tailored approach to molecular imaging1.
Care that can unlock the potential of Theranostics.
Every step of the care you provide is an opportunity to make personalised decisions for your patients. One pathway focused on enabling intelligently efficient and precise, personalised care is Theranostics, the process of bringing together diagnostics and therapeutics.
Care that can discover, diagnose, and treat.
Healthcare’s focus has begun to shift from treatment to risk definition, patient stratification, personalised health promotion, and disease prevention strategies.
In partnership with you, GE HealthCare can play a critical role in the future of molecular imaging with a new, more tailored, more compassionate approach to PET and SPECT/CT.
Are you ready for what’s next?